Company Filing History:
Years Active: 2013
Title: Xianshan Hou: Innovator in Pharmaceutical Chemistry
Introduction
Xianshan Hou is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of important medicinal compounds. His work has led to advancements in the synthesis of dronedarone, a drug used for treating heart conditions.
Latest Patents
Xianshan Hou holds a patent for the "Preparation process of dronedarone and its salts." This innovative process involves reacting 5-amino-2-butyl-3-(4-[3-(dibutylamino)propoxy]benzoyl)benzofuran (compound A) with methanesulfonyl chloride without any catalyst. The result is the production of crude dronedarone hydrochloride, which is then purified to yield a highly pure product. The process also allows for the conversion of dronedarone hydrochloride into other pharmaceutically acceptable salts, enhancing its therapeutic potential.
Career Highlights
Xianshan Hou is associated with Jiangsu Hengrui Medicine Company Ltd., where he continues to contribute to pharmaceutical innovations. His expertise in chemical processes has been instrumental in developing new methods for drug synthesis.
Collaborations
Xianshan Hou collaborates with Yongjiang Chen, a fellow researcher, to further explore advancements in pharmaceutical chemistry. Their combined efforts aim to enhance the efficacy and safety of medicinal compounds.
Conclusion
Xianshan Hou's contributions to the field of pharmaceutical chemistry, particularly through his patent on dronedarone, highlight his role as an innovator in drug development. His work continues to impact the medical field positively.